Jazz Pharmaceuticals plc (1JAZZ)
MTA
Real-time Data
07:00 AM
Day's Range
214.4052 wk Range
103.00Overview - 1JAZZ - Jazz Pharmaceuticals plc
Key Statistics
Valuation
Enterprise Value
13.93B
P/E (Trailing)
‪17.12‬
PEG Ratio
‪-0.13‬
Price / Sales (TTM)
‪3.01‬
Price / Book
‪3.37‬
EV / EBITDA
‪8.44‬
Profitability
Gross Margin
‪90.36%‬
Profit Margin
‪20.44%‬
Operating Margin
‪26.91%‬
Return on Assets
‪6.86%‬
Return on Equity
‪22.11%‬
Ownership
Shares Outstanding
64.80M
Float
62.93M
Held by Insiders
‪2.98%‬
Held by Institutions
‪103.03%‬
Price stats
Beta
‪0.36‬
50-Day Avg
‪210.62‬
200-Day Avg
‪172.82‬
Dividends
Payout Ratio
‪0.00%‬
Peers - 1JAZZ - Jazz Pharmaceuticals plc
Peer Comparison
Compared with companies in Biotechnology listed on MTA.
Profile Summary - 1JAZZ - Jazz Pharmaceuticals plc
About
Jazz Pharmaceuticals plc is a biopharmaceutical company dedicated to identifying, developing, and commercializing innovative medicines that address unmet medical needs in serious diseases. It maintains a diverse portfolio of marketed products targeting rare epilepsies such as with Epidiolex, sleep disorders including…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
